Loading clinical trials...
Loading clinical trials...
Coagulopathy in Childhood Acute Lymphoblastic Leukaemia, Underlying Mechanisms and Ways to Optimise Treatment
Conditions
Interventions
Coagulopathy parameters
Start Date
March 1, 2024
Primary Completion Date
November 1, 2026
Completion Date
November 1, 2028
Last Updated
February 5, 2024
NCT05376111
NCT07410117
NCT04065399
NCT07295951
NCT05453500
NCT05442515
Lead Sponsor
Karolinska University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions